Shao WQ - Search Results

1

Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma.

Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, Lin ZF, Zhao J, Zheng Y, Dong QZ, Lu L, Jia HL, Zhang JB, Lu M, Chen JH, Qin LX. Shao WQ, et al. Cell Rep. 2022 Apr 19;39(3):110712. doi: 10.1016/j.celrep.2022.110712. Cell Rep. 2022. PMID: 35443161 Free article.

2

Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation.

Lin J, Lu M, Shao WQ, Chen ZY, Zhu WW, Lu L, Jia HL, Cai D, Qin LX, Chen JH. Lin J, et al. Among authors: shao wq. Sci Rep. 2016 Aug 3;6:30215. doi: 10.1038/srep30215. Sci Rep. 2016. PMID: 27484115 Free PMC article.

3

Erratum: Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation.

Lin J, Lu M, Shao WQ, Chen ZY, Zhu WW, Lu L, Jia HL, Cai D, Qin LX, Chen JH. Lin J, et al. Among authors: shao wq. Sci Rep. 2017 Mar 22;7:44962. doi: 10.1038/srep44962. Sci Rep. 2017. PMID: 28327561 Free PMC article. No abstract available.

4

Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1.

Lin J, Shao WQ, Chen QZ, Zhu WW, Lu L, Jia HL, Chen JH. Lin J, et al. Among authors: shao wq. Mol Med Rep. 2017 Aug;16(2):1785-1792. doi: 10.3892/mmr.2017.6774. Epub 2017 Jun 14. Mol Med Rep. 2017. PMID: 28627641 Free PMC article.

5

ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition.

Lu M, Zhu WW, Wang X, Tang JJ, Zhang KL, Yu GY, Shao WQ, Lin ZF, Wang SH, Lu L, Zhou J, Wang LX, Jia HL, Dong QZ, Chen JH, Lu JQ, Qin LX. Lu M, et al. Among authors: shao wq. Cell Metab. 2019 Apr 2;29(4):886-900.e5. doi: 10.1016/j.cmet.2018.12.019. Epub 2019 Jan 22. Cell Metab. 2019. PMID: 30661930 Free article.

6

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR.

Shao W, Zhu W, Lin J, Luo M, Lin Z, Lu L, Jia H, Qin L, Lu M, Chen J. Shao W, et al. Neoplasia. 2020 Jan;22(1):1-9. doi: 10.1016/j.neo.2019.08.002. Epub 2019 Nov 18. Neoplasia. 2020. PMID: 31751859 Free PMC article.

7

Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.

Luo M, Liu Y, Liu N, Shao W, Ming L, Liu J, Xie Y. Luo M, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Jan 12;53(1):19-28. doi: 10.1093/abbs/gmaa139. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33201987 Free article.

8

S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma.

Wei R, Zhu WW, Yu GY, Wang X, Gao C, Zhou X, Lin ZF, Shao WQ, Wang SH, Lu M, Qin LX. Wei R, et al. Among authors: shao wq. Int J Cancer. 2021 Mar 1;148(5):1233-1244. doi: 10.1002/ijc.33371. Epub 2020 Nov 17. Int J Cancer. 2021. PMID: 33205453

9

Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.

Yi C, Chen L, Lin Z, Liu L, Shao W, Zhang R, Lin J, Zhang J, Zhu W, Jia H, Qin L, Lu L, Chen J. Yi C, et al. Hepatology. 2021 Nov;74(5):2544-2560. doi: 10.1002/hep.31921. Epub 2021 Aug 25. Hepatology. 2021. PMID: 34036623

10

Rapamycin enhances the anti-tumor activity of cabozantinib in cMet inhibitor-resistant hepatocellular carcinoma.

Gao C, Wang S, Shao W, Zhang Y, Lu L, Jia H, Zhu K, Chen J, Dong Q, Lu M, Zhu W, Qin L. Gao C, et al. Front Med. 2022 Jun;16(3):467-482. doi: 10.1007/s11684-021-0869-y. Epub 2021 Oct 20. Front Med. 2022. PMID: 34669157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters